q4 better be good then....because otherwise Musclepharm will be punished for having delayed disappointing results for two quarters in a row...and it could ultimately depress the stock price throughout 2015...until Musclepharm consistently reports results and guidance in time.
It might be that it is not a bad sign, but merely a question of Musclepharm not having a clue about how much it sells through Walmart and Sam's Club until the end of March. Also, the strengthening dollar makes it harder to predict sales abroad...which could be still growing, but not as much as anticipated.
News 
Market Data 
Discover 
AI
